Related by context. All words. (Click for frequent words.) 63 PREVENT IV 62 fosbretabulin 60 Phase III randomized controlled 60 LUMINATE 59 Phase IIB 59 phase IIb clinical 59 Edwards SAPIEN valve 59 Phase IIIb clinical 58 clinical pharmacology studies 58 multicenter trials 58 multicenter randomized clinical 58 MIST II 58 Randomized Evaluation 58 phase IIb III 57 placebo controlled Phase III 57 multicenter clinical 57 ADVANCE PD 57 Neuradiab 57 Val HeFT 57 Phase IIb III 57 PRECISE 57 ONTARGET 57 OmniWave 57 NeuroStar TMS Therapy 57 LEUKINE 57 RE LY 57 Cloretazine R 56 BR.# 56 phase IIa clinical 56 HepaSphere 56 Phase III psoriasis 56 CHAMPION PCI 56 recurrent glioma 56 multicentre randomized controlled 56 ENGAGE AF TIMI 56 phase IIIb 56 Dacogen injection 56 myocardial revascularization 56 multicenter clinical trials 56 BrachySil TM 56 Merci Retrieval System 56 ReN# 56 PRECISE trial 56 masitinib 56 Phase 1a clinical 56 DAPT 56 ClosureFAST catheter 56 pharmacokinetic PK study 55 BCIRG 55 EndoTAG TM -1 55 R0 resection 55 multicenter prospective 55 Long Lesion 55 STRIDE PD 55 ADAGIO study 55 prospective multicenter 55 EOquin TM 55 Phase #b/#a clinical 55 prospective multicenter study 55 Renal Cell Carcinoma RCC 55 COPERNICUS 55 CCX# 55 RE LY ® 55 riociguat 55 placebo controlled clinical 55 CLARITY study 55 Azedra 55 solid organ transplantation 55 Phase Ib clinical 55 TLK# 55 Phase #b/#a 55 OLYMPIA registry 55 Stenting Trial CREST 55 RELIANT Trial 55 Pivotal Trial 55 MTWA testing 55 MADIT 55 Phase 1b clinical trials 55 APEX AMI trial 55 Carotid 55 CARE HF 55 carotid artery stenting CAS 55 Phase III Psoriasis 55 AIM HIGH 55 NeuroFlo 54 neoadjuvant 54 prospective randomized controlled 54 dosage regimens 54 Acute Decompensated Heart Failure 54 Randomized controlled 54 multicenter randomized controlled 54 carotid artery stent 54 PFO migraine 54 HCV SPRINT 54 refractory angina 54 Current Controlled Trials 54 paclitaxel eluting stents 54 AVADO 54 oral ridaforolimus 54 randomized Phase IIb 54 recurrent GBM 54 REALITY Trial 54 NSABP B 54 subanalysis 54 double blinded randomized 54 Phase IIIb study 54 MADIT II 54 Phase III VISTA 54 preclinical efficacy 54 Cloretazine ® 54 lorcaserin Phase 54 PANVAC VF 54 confirmatory clinical 54 dose escalation phase 54 TAXUS TM 54 ularitide 54 eculizumab therapy 54 Androxal TM 54 CALGB 54 randomized blinded 54 GOUT 54 valve implantation 54 RhuDex 54 SEPET TM 54 trastuzumab DM1 T DM1 54 EchoCRT 53 randomized controlled clinical 53 elective PCI 53 Andara TM OFS 53 ONTARGET R 53 bioresorbable stent 53 TRISENOX 53 MERLIN TIMI 53 LUVENIQ 53 oral anticoagulation 53 subgroup analyzes 53 Liprostin 53 HDL Selective Delipidation 53 IL# PE#QQR 53 Hepatocellular Carcinoma HCC 53 Phase 2b kidney transplant 53 INTERCEPT platelets 53 NCT# ClinicalTrials.gov 53 EURIDIS 53 Electronic Brachytherapy 53 multicenter Phase III 53 AQUAVAN R 53 randomized Phase 2b 53 Thrombolysis 53 ELACYT 53 multicentre randomized 53 ToGA 53 concurrent chemoradiation 53 SPIRIT FIRST 53 ganetespib 53 Vasogen Celacade 53 Hyphanox 53 coronary stenting 53 ENDEAVOR IV 53 PrevOnco 53 CHARM Added 53 TAXUS IV 53 AIR2 Trial 53 PLCO 53 substudy 53 BioSTAR R 53 PERSEUS 53 IMA# 53 Phase IIa clinical trials 53 elacytarabine 53 VITAL Trial 53 CHAMPION PLATFORM 53 UPLYSO 53 NAVISTAR R 53 ACCORD Lipid 53 Embolic Protection Device 53 GAMMAGARD 53 pivotal bioequivalence 53 myoblast therapy 53 pharmacokinetic PK 53 PMA submission 53 Accelerated Partial Breast Irradiation 53 InterStim Therapy 53 phase IIa 53 urethral bulking agent 53 pharmacokinetic characteristics 53 MYTHOS trial 53 OvaRex ® MAb 53 Traficet EN 53 ENESTnd 53 INFUSE ® 53 Vascugel ® 53 CALGB # [002] 53 HPTN 53 brivaracetam 53 Phase Ia 53 MelaFind pivotal 53 Phase Ib study 53 MEND CABG 52 blinded randomized controlled 52 Neovasc Reducer 52 STENT 52 BRIM3 52 double blinded placebo 52 TQT 52 TG MV 52 neoadjuvant treatment 52 cytoreductive nephrectomy 52 CINTREDEKIN BESUDOTOX 52 drug eluting stent DES 52 RE MODEL 52 Randomised 52 EmbraceAC 52 GRAVITAS trial 52 IV NSCLC 52 Carotid Revascularization Endarterectomy vs. 52 NO# [002] 52 TAXUS ATLAS 52 NEVO RES 52 Phase IIIb 52 BST CarGel R 52 placebo controlled Phase 52 CRLX# 52 prospective observational 52 SCD HeFT 52 blinded randomized 52 YONDELIS 52 metastatic neuroendocrine tumors 52 TELCYTA 52 Multicenter 52 multicenter Phase II 52 ACRIN 52 iii GTx 52 ASSERT 52 REG1 52 multicentre prospective 52 EDEMA4 52 AZILECT R 52 Anticoagulation 52 SUTENT ® 52 multicenter randomized placebo controlled 52 Dyloject TM 52 Metricath 52 ACOSOG Z# 52 Intervention Effectiveness CATIE 52 lung resection 52 HeFT 52 mechanical thrombectomy 52 IMPACT DCM 52 PREGNANT Study 52 Cloretazine R VNP#M 52 Microplasmin 52 CYPHER R Sirolimus eluting 52 T1DM 52 ENDEAVOR III 52 Thorough QT 52 Fully Covered Stent 52 NP2 Enkephalin 52 Lumbar Interbody Fusion 52 OvaRex R 52 Elitek 52 LHRH antagonists 52 carotid endarterectomy CEA 52 Provecta 52 phase III ACCLAIM 52 MAGE A3 ASCI 52 BETAS 52 invasive candidiasis 52 EVA 3S 52 catheter occlusion 52 EOquin 52 EsophyX 52 Phase Ib II 52 Viprinex TM 52 omega interferon 52 ENDEAVOR clinical 52 ROCKET AF 52 rALLy trial 52 ENDEAVOR II 52 multicenter placebo controlled 52 Tryton stent 51 Elagolix 51 OvaRex MAb 51 Squalamine 51 Diabetic Macular Edema 51 tanespimycin 51 Prostate Lung Colorectal 51 GSK# [001] 51 Sublative Rejuvenation 51 Endeavor DES 51 RenalGuard TM 51 CURRENT OASIS 7 51 Phase III Clinical Trials 51 TACI Ig 51 squalamine 51 randomized clinical 51 CUSTOM III 51 Allovectin 7 ® 51 TELINTRA 51 GeoVax vaccine 51 multicenter phase 51 sunitinib malate 51 TASKi3 51 RhuDex ® 51 GEM OS1 51 PRESEPT 51 SNT MC# 51 Plicator 51 ZYBRESTAT TM 51 GENASIS trial 51 Pivotal Clinical Trial 51 Mobi C 51 Onalta ™ 51 LungExpress Dx TM 51 WallFlex Biliary RX 51 BLA filing 51 PSMA ADC 51 Ophena 51 ID NCT# 51 IMPACT DCM clinical 51 MOZOBIL 51 ASTEROID 51 recurrent glioblastoma multiforme 51 clinicaltrials 51 rALLy clinical trial 51 PFO closure 51 CBLC# 51 Sibutramine Cardiovascular Outcomes 51 evaluable subjects 51 zotarolimus eluting stent 51 adjuvant therapies 51 antiangiogenic agents 51 designated HVTN 51 CIMZIA TM certolizumab pegol 51 OPAXIO 51 Meta analyzes 51 registrational 51 Hexvix 51 BREVAGen ™ 51 lumbar disc replacement 51 multicenter study 51 prospective multicentre 51 prospective randomized placebo 51 Percutaneous Coronary Intervention 51 multicenter multinational 51 Delcath Phase III 51 AMID Stapler ™ 51 IIb clinical trial 51 ganaxolone 51 NeoDisc 51 ONCONASE R 51 VADT 51 AE# vaccine 51 randomized controlled Phase 51 Virulizin R 51 CLARITY TIMI 51 Cloretazine VNP#M 51 docetaxel Taxotere ® 51 LibiGel Phase III 51 transesophageal echocardiography TEE 51 catheter occlusion CO 51 Anticalin ® 51 Endoscopic Ablation System 51 cerebral oximetry 51 randomized controlled trials RCTs 51 VDAs 51 dexanabinol 51 TEC #OL 51 TriActiv R 51 embolotherapy 51 Phase 2a trial 51 phase IIb trial 51 vidofludimus 51 trastuzumab Herceptin ® 51 placebo controlled randomized 51 GRNVAC1 51 TUMT 51 Phase IIb kidney transplant 51 doxorubicin docetaxel 50 BLA submission 50 randomized multicenter trial 50 neratinib 50 ReN# therapy 50 eprotirome 50 Solazed TM 50 refractory CLL 50 PROMUS Element Stent 50 Bezielle 50 Neo Bladder Augment 50 JAK inhibitor 50 MEND CABG II 50 RSD# oral 50 NSABP 50 antithrombotic therapies 50 Clinical Antipsychotic Trials 50 intravascular stent 50 randomized multicenter Phase III 50 OnControl 50 QuadraSphere 50 IMPACT IMmunotherapy 50 MicroThermX 50 HORIZONS AMI trial 50 antihypertensive therapies 50 multicentre 50 Cotavance 50 CAMMS# 50 metastatic CRC 50 COMFORT II 50 ACCLAIM 50 autologous SCT 50 external counterpulsation 50 prospective randomized multicenter 50 Oral Insulin Capsule 50 ORMD 50 DXL# 50 phase Ib clinical 50 e2 Collector 50 drug eluting coronary stents 50 Aggressive Drug Evaluation 50 KRN# 50 PREVU x LT 50 bifurcation stent 50 HDR brachytherapy 50 Feasibility Trial 50 Xanafide 50 rALLy 50 DAPT Study 50 nonrandomized 50 percutaneous interventions 50 Phase III TRIST 50 ATAC Arimidex Tamoxifen Alone 50 Levacor 50 BrachySil 50 coronary revascularization 50 Phase IIa trials 50 PROSTVAC TM 50 RCTs 50 Aloxi injection 50 IMPROVE HF 50 tumor excision 50 Ophena TM 50 NEUVENGE 50 Fibrillex TM 50 Azedra ™ 50 reperfusion therapy 50 ImmuKnow R 50 EDEMA3 50 TAXUS Liberte Stent 50 CompuFlo 50 satraplatin Phase 50 Zemiva ™ 50 postoperative chemotherapy 50 EORTC 50 SpyGlass System 50 EDEMA3 trial 50 Cellegesic 50 postapproval 50 MVax R 50 Vascular Imaging 50 dirucotide 50 5-fluorouracil/leucovorin 50 ARCOXIA 50 APTIVUS 50 Rilonacept 50 Stedivaze 50 BNC# 50 INCB# [001] 50 fidaxomicin Phase 3 50 PGL# 50 thorough QT 50 Vascular Wrap TM 50 BioDisc 50 ClosureFAST 50 ZYBRESTAT fosbretabulin 50 EMPHASIS HF 50 Resten NG 50 TOLAMBA 50 Urocidin TM 50 TMC# C# 50 thoracoscopic lobectomy 50 Screening Trial DMIST 50 decitabine 50 clinically localized prostate 50 Medidur TM FA 50 PREOS R 50 PROMACTA CARES 50 F FDG PET 50 Prostate Cancer Prevention 50 trials RCTs 50 vein ablation 50 dose escalation Phase 50 dose escalation clinical 50 QTinno TM 50 Cellulaze 50 TEMSO 50 Raloxifene Evaluation MORE 50 chronic myocardial ischemia 50 Rubicon Filter 50 randomized Phase III 50 Iluvien TM 50 DACH platinum 50 Litx 50 embolisation 50 Myocet 50 ECASS 50 CABANA 50 Zemplar Capsules 50 Advagraf 50 Zevalin consolidation 50 RX ACCULINK 50 assessing T DM1 50 thrombolytic agents 50 percutaneous catheter 50 Raptiva ® 49 tramiprosate Alzhemed TM 49 alvespimycin 49 ALSYMPCA 49 treatment naive genotype 49 intravesical therapy 49 CardioFit 49 WATCHMAN device 49 HQK 49 QUADRAMET R 49 National Emphysema Treatment 49 CryoPlasty 49 SPIRIT IV 49 EVEREST II 49 ASCEND HF 49 balloon valvuloplasty 49 canakinumab 49 rindopepimut 49 EFAPROXYN 49 VNP#M 49 HIPEC 49 BLP# Liposome Vaccine 49 forodesine 49 Powerlink System 49 AZOR 49 cytoreduction 49 hESC derived RPE cells 49 myopic CNV 49 coronary intervention 49 SYNTAX trial 49 ureteral stents 49 candidate CRLX# 49 PET tracers 49 NATRECOR R 49 Exherin TM 49 acute HAE attacks 49 thrombolytics 49 Vascugel 49 pain palliation 49 immunotherapeutic vaccine 49 afamelanotide 49 EsophyX TM 49 OHR/AVR# 49 Amrubicin 49 rBChE 49 octreotide implant 49 oral taxane 49 Zilver PTX 49 ALLHAT 49 Phase III confirmatory 49 omecamtiv mecarbil 49 zileuton IV 49 Alequel 49 endoscopic ultrasound 49 PEGylated interferon 49 CATIE AD 49 IMPELLA 49 triphendiol 49 ACTIVE W 49 identifier NCT# 49 Bicifadine 49 Glybera R 49 THALOMID 49 ILLUMINATE 49 Initiated Phase 49 Onconase 49 LUX Lung 49 pharmacodynamic PD 49 Drug Eluting Stent System 49 Placebo controlled 49 Prednisporin TM 49 lymphadenectomy 49 Intervention Effectiveness 49 TROPIC 49 Combo Stent 49 budesonide foam 49 MGuard ™ 49 DEEP AF 49 Prostate AdenoCarcinoma Treatment 49 Phase 2b dose 49 trastuzumab emtansine T DM1 49 Phase III Pivotal 49 CLORETAZINE TM VNP#M 49 ORBIT II 49 placebo controlled trials 49 Perforomist ™ Inhalation Solution 49 Phase #b/#a trial 49 genotypic resistance 49 Valiant Thoracic Stent Graft 49 CINQUIL 49 viral kinetic 49 EGS# 49 carotid stent 49 Aggrenox ® 49 cortical stimulation 49 evaluating REVLIMID 49 Hedgehog antagonist 49 PREVAIL 49 metastatic HRPC 49 HF ACTION 49 Percutaneous Coronary Interventions 49 Alvesco R 49 obatoclax 49 Embolic Protection System 49 HeartMate R 49 Symadex 49 punctal plug delivery 49 Circulatory Support 49 confirmatory Phase III 49 SUTENT 49 hypercholesterolemic patients 49 Ovarian Cancer Screening 49 BARI 2D 49 DCVax ® Brain 49 PEARL SC 49 tumor necrosis 49 PROLARIS 49 FORE SIGHT Absolute Cerebral 49 Octreolin 49 secondary efficacy endpoints 49 HSCT 49 Advaxis Phase 49 neoadjuvant therapy 49 PCA3 test 49 Prodarsan 49 PROSTVAC VF 49 Phase III registrational 49 preclinically 49 Plasmin 49 PROTECT AF 49 Phase 1b clinical 49 Ablatherm 49 paclitaxel poliglumex 49 Phase 2a preventative 49 AF ablation 49 Sorafenib HCC Assessment 49 AZILECT ® 49 Cytolin R 49 relapsed MM 49 severe hypercholesterolemia 49 OMNARIS HFA 49 RIGScan CR 49 Elocalcitol 49 extracorporeal circulatory support 49 Alfimeprase 49 anti angiogenic agents 49 ABSORB trial 48 Phase lll 48 Rheos System 48 Ascendra 48 Fludara ® 48 CEQ# 48 pelvic lymphadenectomy 48 ANCHOR trial 48 atrial fibrillation ablation 48 lanreotide 48 sNDA submission 48 BRIM2 48 omacetaxine mepesuccinate 48 prospective observational studies 48 STARFlex 48 AVERROES 48 ProUroScan 48 EP #R 48 LEP ETU 48 AeroLEF TM 48 VIR# 48 Phase IIb clinical trials 48 tolevamer 48 Phase #/#a trial 48 ASSERT trial 48 Phase 2b clinical 48 Phase 2b study 48 VisuMax 48 ACS NSQIP 48 miRview meso 48 cluster randomized controlled 48 CRMD# 48 MAA submission 48 SYMMETRY trial 48 Turbo Tandem 48 ClearPath HDR 48 Solazed 48 iclaprim 48 SUCCEED trial 48 NOX E# 48 PRIMO CABG 48 aerosolized KL4 surfactant 48 galiximab 48 radiation sensitizer 48 embolic protection 48 phase III isavuconazole 48 RTOG 48 Cholesterol Levels SPARCL 48 BrachySil ™ 48 novel oral anticoagulant 48 CUSTOM II 48 lomitapide 48 receptor tyrosine kinase inhibitor 48 Phase III HEAT 48 PD2i CA 48 OVATURE 48 perfusion MRI 48 percutaneous cryoablation 48 randomized controlled clinical trials 48 HCV RESPOND 2 48 non squamous NSCLC 48 postoperative radiotherapy 48 Augment Injectable Bone Graft 48 postmenopausal osteoporotic women 48 alemtuzumab Campath 48 percutaneous aortic valve 48 dosing cohorts 48 ADVEXIN clinical 48 clinical endpoints 48 evaluating mipomersen 48 keratoplasty 48 nonclinical studies 48 Fentanyl TAIFUN R 48 CentriMag 48 romidepsin 48 Multicenter Automatic Defibrillator Implantation 48 balloon brachytherapy 48 Ereska 48 multicenter Phase 48 Asentar 48 VentrAssist 48 Phase 2a clinical trials 48 Edge STudy 48 DUROS 48 AgaNase 48 Dupuytren Disease 48 PRECiSE 48 prospective multicenter randomized 48 pacemaker implantation 48 Phase 2a clinical 48 Vectibix monotherapy 48 crizotinib PF # 48 XL# SAR# 48 external counterpulsation systems 48 clinical trials 48 ticagrelor Brilinta 48 Augment Injectable 48 confirmatory Phase 48 including eniluracil ADH 48 NLX P# 48 Cytolin ® 48 relapsed ALL 48 Anturol TM 48 DEB# 48 SYNTAX 48 phase IIb 48 ERCP 48 dextofisopam 48 lenalidomide Revlimid R 48 lintuzumab 48 CLIRS trial 48 Metricath Gemini 48 Aurexis 48 clinical trial 48 Epanova 48 pertuzumab 48 Phase Ib IIa clinical 48 WHIMS 48 enroller 48 Aryplase 48 Powerlink XL 48 neoadjuvant chemotherapy 48 LC#m# 48 Alocrest 48 Medtronic CoreValve ® 48 cytotoxic therapy 48 ongoing Phase 1b 48 DCCR 48 refractory prostate cancer 48 MoxDuo IR 48 EverFlex 48 Artelon ® 48 OMS#HP 48 Dupuytren Contracture 48 ATryn ® 48 HOPE TOO 48 Surfaxin LS 48 HDF therapy 48 Contura MLB 48 Occluder 48 BEZ# 48 Xelox 48 LPM TM 48 Secondary efficacy endpoints 48 Factor VIIa 48 IMPROVE IT 48 iSONEP 48 PREOS 48 goserelin 48 Exer Rest ® 48 Excimer Laser 48 CONDOR 48 Dr. Sosne 48 TRANSFORMS 48 TREDAPTIVE 48 breast brachytherapy 48 torezolid phosphate 48 REMEDIAL II 48 SANVAR 48 Twinrix 48 Stabilimax NZ 48 Phase III ADT 48 EXPLORE Xa 48 TYSABRI natalizumab 48 MGN# 48 Pimavanserin 48 underwent resection 48 Cardiac Resynchronization Therapy 48 placebo controlled studies 48 POISE 48 hepatitis B vaccine Heplisav 48 pediatric acute lymphoblastic 48 eosinophilic asthma 48 remission CR 48 FOLPI 48 Somatuline R Autogel R 47 multicentre study 47 Nuvion 47 ORAL Sync 47 liquid embolic 47 warfarin therapy 47 transapical 47 TriGrid 47 vertebral compression fractures 47 IVC filters 47 Civacir 47 RIO Lipids 47 Phase 2b trial 47 Phase #/#a 47 intratumoural 47 APEX PD 47 carotid stents 47 tecarfarin 47 ALN PCS 47 Fibrin Pad 47 Bioral ® 47 PARTNER Trial 47 TQT studies 47 XP# XP# 47 CRp 47 EVIZON 47 PreCISe 47 chemoprevention trials 47 Phase IIA 47 ISEL 47 eTag assays 47 unicompartmental knee replacement 47 OsseoFix 47 Plicera 47 TASKi2 47 ROTATEQ 47 number NCT# ClinicalTrials.gov 47 eSVS MESH 47 ponatinib 47 metastatic castration resistant 47 VALSTAR 47 MYDICAR 47 Thrombectomy System 47 Soliris eculizumab 47 ProSavin 47 COSIRA trial 47 Defibrillation 47 AOD# [002] 47 OvaRex 47 ACUITY trial 47 AVOREN 47 Stretta 47 Phase 1b trial 47 histamine dihydrochloride 47 blinded randomized placebo controlled 47 PXD# 47 TBC# 47 IIa clinical 47 Study ADCS 47 Novacor II 47 Dose escalation 47 afatinib 47 REGARDS 47 Pagoclone 47 thrombolytic therapy 47 dose cohorts 47 Amphotericin B 47 OncoVEX GM CSF 47 registrational trial 47 PIX# [002] 47 drug ISA# 47 Intraject 47 placebo controlled clinical trials 47 Exer Rest R 47 endovascular aneurysm repair 47 opioid induced bowel dysfunction 47 ENTEREG ® 47 Septin9 47 cetrorelix pamoate 47 R#/MEM 47 Isolagen Process 47 SCENESSE ® 47 pharmacokinetic PK profile 47 tesmilifene 47 RenalGuard System TM 47 AMID Stapler TM 47 oxymorphone ER 47 Intravail R 47 QVAR 47 PROSTVAC ® 47 AIR CF1 47 iroxanadine 47 TOCOSOL Paclitaxel 47 ThromCat 47 unique alkylating agent 47 Stabilimax 47 GLP toxicology studies 47 atacicept 47 teriflunomide 47 DCVax R 47 adjuvant tamoxifen 47 lumiliximab 47 overactive bladder syndrome 47 IORT 47 IN.PACT Falcon 47 DCVax R Brain 47 Velcade bortezomib 47 Surgical Ablation System 47 GELA 47 relapsing remitting MS RRMS 47 clinical 47 ancrod 47 paroxetine Seroxat 47 HuMax CD4 47 INTEGRILIN ® 47 MIRCERA 47 hoFH 47 LensAR Laser System 47 prospective randomized 47 Phase 1b dose escalation 47 lymphatic mapping 47 XIENCE 47 #L Ozone Sterilizer 47 oral rivaroxaban 47 BioControl 47 Phase Ib IIa 47 CVBT #H 47 implantations 47 cannabinor 47 transfemoral 47 zanolimumab 47 SIMPADICO 47 CorPath 47 tezampanel 47 Phase IIa trial 47 Cardiac Cryoablation System 47 Phase 2b monotherapy 47 AngioJet thrombectomy 47 GRN# 47 OvPlex ™ 47 intradermal injection 47 blinded placebo controlled 47 Viveta 47 ascending dose 47 Biliary System 47 multicentre randomized double 47 Phase IIa clinical 47 Trovax 47 trial evaluating PRX# 47 European Sepsis Trial 47 Talent Abdominal Stent Graft 47 TransMID 47 bardoxolone 47 Cleviprex TM clevidipine 47 Telatinib 47 oral FTY# 47 Phase Ib 47 direct thrombin inhibitors 47 APPRAISE 47 Urocidin 47 Endurant 47 IIa trials 47 phase IIb study 47 transcatheter closure 47 OMS#